UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer

Gynecologic oncology, 2008-01, Vol.108 (1), p.42-46

2008

Volltextzugriff (PDF)

Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study

European journal of cancer (1990), 2017-09, Vol.82, p.230-236

2017

Volltextzugriff (PDF)

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-08, Vol.51 (8), p.1082-1086

2016

Volltextzugriff (PDF)

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

Journal of clinical oncology, 1997-01, Vol.15 (1), p.251-260

1997

Volltextzugriff (PDF)

Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes

European journal of cancer care, 2012-03, Vol.21 (2), p.242-250

2012

Volltextzugriff (PDF)

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

British journal of cancer, 2014-03, Vol.110 (6), p.1413-1419

2014

Volltextzugriff (PDF)

Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy

European journal of surgical oncology, 2009-09, Vol.35 (9), p.916-920

2009

Volltextzugriff (PDF)

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

British Journal of Cancer, 2000-12, Vol.83 (11), p.1480-1487

2000

Volltextzugriff (PDF)

A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients

Annals of oncology, 2006-03, Vol.17 (3), p.429-436

2006

Volltextzugriff (PDF)

Breast Cancer Patients’ Views on the Use of Genomic Testing to Guide Decisions about Their Postoperative Chemotherapy

Public health genomics, 2013-01, Vol.16 (3), p.110-117

2013

Volltextzugriff (PDF)

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction

Clinical cancer research, 2000-08, Vol.6 (8), p.3117-3122

2000

Volltextzugriff (PDF)

Pharmacokinetics and safety profile of oxaliplatin

Seminars in oncology, 1998-04, Vol.25 (2 Suppl 5), p.13

1998

Volltextzugriff (PDF)

Primary Chemotherapy for Operable Breast Cancer: Incidence and Prognostic Significance of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery

Journal of clinical oncology, 2001-09, Vol.19 (18), p.3828-3835

2001

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

Annals of oncology, 1995-02, Vol.6 (2), p.141-151

1995

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients

Cancer research (Chicago, Ill.), 1994-08, Vol.54 (16), p.4347-4354

1994

Volltextzugriff (PDF)

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

Bone marrow transplantation (Basingstoke), 2006-04, Vol.37 (7), p.651-659

2006

Volltextzugriff (PDF)

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients

Annals of oncology, 2001-02, Vol.12 (2), p.231-237

2001

Volltextzugriff (PDF)

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma : An investigator-originated compassionate-use experience

Annals of oncology, 1999-09, Vol.10 (9), p.1125-1128

1999

Volltextzugriff (PDF)

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3097-3104

1996

Volltextzugriff (PDF)

High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1080-1086

1997

Volltextzugriff (PDF)

Erratum: Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2017-03, Vol.52 (3), p.498-498

2017

Volltextzugriff (PDF)

Patient preference of trastuzumab administration (SC versus IV) in HER2-positive metastatic breast cancer: Results of the randomised Metaspher study

Annals of oncology, 2016-10, Vol.27, p.vi85-vi85

2016

Volltextzugriff (PDF)

High-dose chemotherapy for inflammatory breast cancer: impact of immunohistochemical status on survival outcome

Annals of oncology, 2016-10, Vol.27, p.vi93-vi93

2016

Volltextzugriff (PDF)

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2017-03, Vol.52 (3), p.498-498

2017

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

Cancer research (Chicago, Ill.), 1993-03, Vol.53 (5), p.1037-1042

1993

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(102)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(94)
Female
(76)
Science & Technology
(70)
Life Sciences & Biomedicine
(68)
Adult
(65)
Middle Aged
(56)
Oncology
(49)
Biological And Medical Sciences
(44)
Medical Sciences
(43)
Aged
(42)
Chemotherapy
(32)
Male
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Breast Neoplasms - Drug Therapy
(28)
Pharmacology. Drug Treatments
(27)
Antineoplastic Agents
(25)
Breast Cancer
(22)
Breast Neoplasms - Pathology
(15)
Neoplasms - Drug Therapy
(15)
Prognosis
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer

Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients

Breast Cancer Patients’ Views on the Use of Genomic Testing to Guide Decisions about Their Postoperative Chemotherapy

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction

Pharmacokinetics and safety profile of oxaliplatin

Primary Chemotherapy for Operable Breast Cancer: Incidence and Prognostic Significance of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma : An investigator-originated compassionate-use experience

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method

High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study

Erratum: Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Patient preference of trastuzumab administration (SC versus IV) in HER2-positive metastatic breast cancer: Results of the randomised Metaspher study

High-dose chemotherapy for inflammatory breast cancer: impact of immunohistochemical status on survival outcome

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Phase I and pharmacokinetic study of taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

Suchergebnisse filtern